DAFTAR PUSTAKA
Abdillah, R. 2012. Dampak Penggunaan Diuretika Terhadap Elektrolit Tubuh dan Fungsi Ginjal pada Pasien Congestif Heart Failure Rawat Inap di Bangsal Jantung RSUP. Dr. M. Djamil Padang. Skripsi pada Fakultas Farmasi Universitas Andalas Padang. Abraham, R. R. & A. S. M. Devi. 2013. Drug Related Problems and Reactive Pharmacist Intervention for Inpatients Receiving Cardiovascular Drug. Am J Pharm Tech Res. 2(3): 1154-1166. Ahmed, A., W. S. Aronow & J. L. Fleg. Higher New York Heart Association Classes and Increased Mortality and Hospitalization in Heart Failure Patients with Preserved Left Ventricular Function. Am Heart J. 151(2): 444–450. Ahmed, A., F. Zannad, T. E. Love, J. Tallaj, M. Gheorghiade, O. J. Ekundayo & B. Pitt. 2007. A propensity-matched study of the association of low serum potassium levels and mortality in chronic heart failure. Eur Heart J. 28:1334-1343. Anand, I. S., T. S. Rector, M. Kuskowski, S. Thomas, N. J. Holwerda & J. N. Chon. 2008. Effect of Baseline and Changes in Systolic Blood Pressure Over Time on the Effectiveness of Valsartan in the Valsartan Heart Failure Trial. Circ Heart Fail. 1:34-42. Arini, N. P. 2013. Studi Penggunaan Obat pada Pasien Gagal Jantung yang Dirawat Inap di RSUD Dr. Soetomo Surabaya. Skripsi pada Fakultas Farmasi Universitas katolik Widya Mandala Surabaya. Ashraf, M. S. & W. Vongpatanasin. 2006. Estrogen and Hypertension. Curr Hypertens Rep. 8:368–376. Ather. S., W. Chan, B. Bozkurt, D. Aquilar, K. Ramasubbu, A. A. Zachariah, X. H. Wehrens & A. Deswal. 2012. Impact of Noncardiac Comorbidities on Morbidity and Mortality in a Predominant Male Population with Heart Failure and Preserved Versus reduced Ejection Fraction. J Am Col Cardiol. (59)998-1005. Bakris, G.L., M. Williams, L. Dworkin, W. J. Elliott, M. Epstein, R. Toto, K. Tuttle, J. Douglas, W. Hsueh & J. Sowers. 2000. Preserving renal function in adults with hypertension and diabetes: A consensus approach. Am J Kidney Dis. 36(3):646-661. Bauer, L.A. 2006. Clinical Pharmacokinetics Handbook. Washington: McGrawHill Companies.
Bonnemeier, H., G. Richard, J. Potratz, U. K. Wiegand, A. Brandes, N. Kluge & H. A. Katus. 2003. Circadian profile of cardiac autonomic nervous modulation in healthy subjects: differing effects of aging and gender on heart rate variability. J Cardiovasc Electrophysiol. 14:791–9. Bouvy, M. L., E. R. Heerdink, H. G. M. Leufkens, A & W. Hoes. 2003. Predicting mortality in patients with heart failure: a pragmatic approach. Heart. 89:605–609. Bowling, C. B., B. Pitt & M. I. Ahmed. 2010. Hypokalemia and Outcomes in Patients with Chronic Heart Failure and Chronic Kidney Disease: Findings from Propensity-Matched Studies. Circ Heart Fail. 3(2):253-260. Bueno, H., J. S. Ross, Y. Wang, J. Chen, M. T. Vildan, S. L. Normand, J. P. Curtis, E. E0- Drye, J. H. Lichtman, P. S. Keenan, M. Kosiborod & H. M. Krumholz 2010. Trends in length of stay and short-term outcomes among Medicare patients hospitalized for heart failure, 1993–2006. J Am Med Assoc. 303:2141–2147. Carolline, S. (2011). Penyakit penyerta dan gaya hidup pada penyakit Congestive Heart Failure (CHF) di RS. Dr. Wahidin Sudirohusodo dan RS.Stella Maris Makassar Tahun 2011. Skripsi pada Fakultas Kedokteran Universitas Hassanudin Makasar. Casper, M., I. Nwaise & J. B. Croft. 2010. Geographic Disparities in Heart Failure Hospitalization Rates Among Medicare Beneficiaries. J Am Coll Cardiol. 55(4):294–249. Clealand, J., H. Dargie, S. Hardman, T. McDonagh & P. Mitchell. 2013. National Heart Failure Audit. British Society for Heart Failure. https://www.ucl.ac.uk/nicor/audits/heartfailure/documents/annualreports/h fannual12-13.pdf Cowie, M. R., D. A. Wood, A. J. S. Coats, S. G. Thompson, P. A. Poole-Wilson, V. Suresh & G. C. Sutton. 1999. Incidence and Aetiology of Heart Failure. Eur J Heart Fail. 20: 421-428. Damayanti, A. 2009. Kajian Drug Related Problems (DRPs) pada Terapi Pasien Congestive Heart Failure (CHF) di Rumkital Dr. Ramelan Surabaya. Tesis pada Farmasi Klinik Universitas Gadjah Mada Yogyakarta. Davey, Patrick. 2005. Medicine At A Glance. Alih Bahasa: Rahmalia. A, & R. Novianty. Jakarta: Erlangga. DeBiasi, E. M., M. A. Pisani, T. E. Murphy, K. Araujo, A. Kookoolis, C. Argebto & J. Puchalski. 2015. Mortality among pastient eith pleural effusion undergoing thoracentesis. Eur Respir J. doi: 10.1183/09031936.00217114 Delima, M. Laurentia, & S. Hadi. 2009. Prevalensi dan Faktor Determinan Penyakit Jantung di Indonesia. Buletin Penelitian Kesehatan. 37(3): 142159.
Deursen, V. M., R. Urso, C. Laroche, K. Damman, U. Dahlström, L. Tavazzi, A. P. Maggioni & A. A. Voors1. 2013. Co-morbidities in Patient with Heart Failure: an analysis of the European Heart Failure Pilot Survey. Eur J Heart Fail. 16: 103–111. Dickstein, K., A. Cohen-Solal, G. Filippatos, P. Ponikowski, P. Poole-Wilson, A. Strömberg, D. J. van Veldhuisen, D. Atar, A. W. Hoes, A. Keren, A. Mebazaa, M. Nieminen, S. G. Priori & K. Swedberg. 2008. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. (29):2388–2442. DiPiro, J.T., Talbert, R.L., Yee, G.C., Matzke, G.R., Wells, B.G., & Posey, B.M. 2011. Pharmacotherapy: A Patophysiologic Approach (8th edition). New York: McGraw-Hill. Ditjen
Yanmedik. 2001. Statistik rumah sakit di Indonesia. Seri 3. Morbiditas/mortalitas. Edisi tahun 2001. Jakarta: Departemen Kesehatan Republik Indonesia.
Ditjen
Yanmedik. 2004. Statistik rumah sakit di Indonesia. Seri 3. Morbiditas/mortalitas. Edisi tahun 2041. Jakarta: Departemen Kesehatan Republik Indonesia
Duerden, M., Tony Avery & Rupert Payne. 2013. Polypharmacy and Medicines Optimization. London: The King’s Fund. Ekawati, A. & W. Afridah. 2015. Hubungan antara Lama Hari Rawat dengan Antrian Masuk Rumah Sakit pada Pasien BPJS Di RS. Islam Jemursari Surabaya. Jurnal Ilmiah Kesehatan. 8:97-103. Fachrunnisa, S. Nurchayati & Arneliwati. 2015. Faktor-faktor yang berhubungan dengan kualitas tidur pasien congestive heart failure. JOM. 12(2). 10941105. Fauci, A. S., D. L. Kasper, D. L. Longo, E. Braunwald, S. L. Hauser, J. L. Jameson & J. Loscalzo. 2008. Harrison’s Principles of Internal Medicine. Volume 2. 17th ed. USA: McGrawHill. Fauci, A. S., S. L. Hauser, D.L. Longo, J. L. Jameson & J. Loscalzo. 2009. Harrison’s Manual of Medicine (17th ed). USA: McGrawHill. Filippatos, Theodosios D. & M. S. Elisaf. 2013. Hyponatremia in patients with heart failure. World J Cardiol. 5(9): 317-328. Forman, D.E., J. Butler, Y. Wang, W. T. Abraham, C. M. O’Connor, S. S. Gottlieb, E. Loh, B. M. Massie, M. W. Rich, L. W. Stevenson, J. B. Young & H. M. Krumholz. 2004. Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure. J Am Coll Cardiol; 43:61-67.
Gheorghiade, M., J. S. Rossi, W. Cotts, D. D. Shin, A. S. Hellkamp, I. L. Piña, G. C. Fonarow, T. DeMarco, D. F. Pauly, J. Rogers, T. G. DiSalvo, J. Butler, J. M. Hare, G. S. Francis, W. G. Stough & C. M. O'Connor. 2005. Hemodynamic characterization and prognostic value of persistent hyponatremia in patients with severe heart failure in the ESCAPE trial. J Am Coll Cardiol. 167(18) 1998-2005. Goldenberg, I., A. J. Moss, S. McNitt, W. Zareba, W. J. Hall & M. L. Andrews. 2007. Inverse Relationship of Blood Pressure Levels to Sudden Cardiac Mortality and Benefit of the Implantable Cardioverter-Defibrillator in Patients With Ischemic Left Ventricular Dysfunction. J Am Coll Cardiol. 49(13): 1427-1433. Gregg, C. F., W. T. Abraham, N. M. Albert, W. Gattis M. Stough, Gheorghiade, B. H. Greenberg, C. M. O'Connor, K. Pieper, J. L. Sun, C. W. Yancy & J. B. Young. 2007. Influence of a PerformanceImprovement Initiative on Quality of Care for Patients Hospitalized With Heart Failure. Arch Inter Med. 167(14):1493-1502. Guyton, A. C. & J. E. Hall. 1996. Textbook of Medical Physiology (9th Ed). Diterjemahkan oleh Irawati Setiawan dkk; Buku Ajar Fisiologi Kedokteran (Edisi 9). Jakarta: Penerbit Buku Kedokteran EGC. Hadiatussalamah. 2013. Identifikasi Drug Related Problem (DRPs) pada Pasien dengan Diagnosis Congestive Heart Failure di Instalasi Rawat Inap RSUP Dr. Mohammad Hoesin Palembang Tahun 2012. Tesis pada Farmasi Klinik Universitas Gadjah Mada Yogyakarta. Heart Foundation. 2015. Women and Heart Disease Ed 3rd. Australia: The National Heart Foundation. Hellermann, J.P., Goraya, T.Y., Jacobsen, S.J., Weston, S.A., Reeder, G.S., Gersh, B.J., Redfield, M.M., Rodheffer, R.J., Yawn, B.P. & Roger, V.L., 2003. Incidence of heart failure after myocardial infarction: is it changing over time?. Am. J. Epidemiology 157 (12): 1101–1107. Heo, S. T. A. Lennie, C. Okoli & D. K. Moser. 2009. Quality of life patients with heart failure: ask the patients. Heart Lung. 38(2):100-108. Holland, R. B. Rechel, K. Stepien, I. Harvey, & I. Brooksby. 2010. Patient’s Self –Assessed Functional Status in Heart Failure by New York Heart Association Class: A Prognostic Predictor of Hospitalization, Quality of Life and Death. J Card Fail. 16(2): 150-156. Hori, Masatsugi & Hiroshi Okamoto. 2012. Heart rate as a target of treatment of chronic heart failure. J Cardiol. 60:86–90.
Hunt, S. A., W. T. Abraham, M. H. Chin, A. M. Feldman, G. S. Francis, T. G. Ganiats, M. Jessup, M. A. Konstam, D. M. Mancini, K. Michl, J. A. Oates, P. S. Rahko, M. A. Silver, L. W. Stevenson & C. W. Yancy. 2005. ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary. J Am Coll Cardiol. (104) :2996-3007. Jessup, M & S. Brozena. 2003. Heart Failure. N Eng J Med. (348):2007-2018. Joshi, A. V., A. O. D’Souza & S. Madhavan. 2004. Differences in Hospital Length of Stay, Charges, and Mortality in Congestive Heart Failure Patients. LEJAQ. 76-84. Kaplan, V., D. C. Angus, M. F. Griffin, G. Clermont, W. Scott, R. Watson & W. T. Linde-Zwirble. 2002. Hospitalized community-acquired pneumonia in the elderly: age- and sex-related patterns of care and outcome in the United States. Am J Respir Crit Care Med. 165(6):766-72. Katzung, B. G., S. B. Masters & A. J Trevor. 2009. Basic & Clinical Pharmacology, 11th Ed. New York:McGraw-Hill. Khasnis, A., K. Jongnarangsin, G. Abela, S, Veerareddy, V. Reddy & R. Thakur. 2005. Tachycardia-induced cardiomyopathy: a review of literature. Pacing Clin Electrophysiol. 28:710-721. Klein, L., M. O’Connor, D. Leimberger, W. Gattis-Stough, I. L. Piña, Felker, G. M. Adams, R. M. Califf & M. Gheorghiade. 2005. Lower serum sodium is associated with increased short-term mortality in hospitalized patients with worsening heart failure: results from the Chronic Heart Failure (OPTIMECHF) Study. Circulation. 111:2454–2460 Kondo, T., T. Yamada, T. Morita, Y. Furukawa, K. Tanaka, Y. Iwasaki, M. Kawasaki, Y. Kuramoto, T. Fujimoto, H. Yamamoto, K. Sengoku, K. Ozu & M. Fukunami,. 2012. Spironolactone Improves Poor Outcome in Patients With NYHA Class I or II Chronic Heart Failure and Elevated Cardiac Sympathetic Nerve Activity. J Am Coll Cardiol. 59(13). Kossovsky, M. P., F. P. Sarasin, P. Chopard, M. Louis-Simonet, P. Sigaud, T. V. Perneger & J. M. Gaspoz. 2002. Relationship between hospital length of stay and quality of care in patients with congestive heart failure. Qual Saf Health Care. (11):219–223. Kovesdy, C. P. 2014. Management of hyperkalaemia in chronic kidney disease. Nat Rev Nephrol. 10(11):653-662. Kwok, B. W. K. 2004. Medical Therapy in Heart Failure-Is Polypharmacy Necessary?. Ann Acad Med Singapore. 33:444-450. Lee, C. S., C. V. Chien & J. T. Bidwell. 2014. Comorbidity profiles and inpatient outcomes during hospitalization for heart failure: an analysis of the U.S. Nationwide inpatient sample. BMC Cardiovascular Disorders. 14:73-81.
Lee, Tobias T., J. Chen, D. J. Cohen & Lana Tsao. 2006. The Association Between Blood Pressure and Mortality in Patients With Heart Failure. Am Heart J. 151(1):7683. Leier, C.V., L. Dei Cas & M. Metra. 1994. Clinical relevance and management of the major electrolyte abnormalities in congestive heart failure: hyponatremia, hypokalemia, and hypomagnesemia. Am Heart J. 128:564– 574. Levy, D., S. Kenchaiah, M. G. Larson, E. J. Benjamin, M. J. Kupka, K. K. Ho, J. M. Murabito & R. S. Vasan. 2002. Long-term trends in the incidence of and survival with heart failure. N Engl J Med. (347): 1397-1402. Light, R. W. 2011. Pleural Effusions. Med Clin North Am. 95(6):1055–70. Lindefeld J. A. 2010. Executive Summaries: HFSA 2010 Comprehensive Heart Failure Practice Guideline. J Card Fail. 16:6:475-503. Lip, G. Y. H., C. R. Gibbs & D. G. Beevers. 2000. Aetiology. BMJ. 320:104-107.
ABC of Heart Failure:
Lydia A, Nugroho P. 2014. Tes fungsi ginjal. Dalam Sudoyo AW, Setiyohadi B, Alwi I, SimadibrataM, Setiati S, editor. Buku ajar Ilmu Penyakit Dalam. Edisi 6. Jakarta: Pusat Penerbitan Ilmu Penyakit Dalam. Macdonald, J. E. & A. D. Struther. What Is the Optimal Serum Potassium Level in Cardiovascular Patients? J Am Coll Cardiol. 43:155–61. Maggioni, A. P., U. Dahlstrom, G. Filippatos, O. Chioncel, M. C. Leiro, J. Drozdz, F. Fruhwald, L. Gullestad, D. Logeart, M. Metra, J. Parissis, H. Persson, P. Ponikowski, M. Rauchhaus, A. Voors, O. W. Nielsen, F. Zannad, L. Tavazzi. 2010. EURObservational Research Programme: the Heart Failure Pilot Survey (ESC-HF Pilot). Eur J Heart Fail. 12:1076– 1084. Malyszko, J., H. Bachorzewska-Gajewska, J. Malyszko, N. Levin-Iaina, Iaina A &Dobrzycki S. 2010. Prevalence of Chronic Kidney Disease and Anemia in Patients with Coronary Artery Disease with Normal Serum Creatinine Undergoing Percutaneous Coronary Interventions: Relation to New York Heart Association Class. I Med Assoc J. 12: 488-492. Mastromarino, V. M. Casenghi, M. Testa, E. Gabriele, R. Coluccia, S. Rubattu & M. Volpe. 2014. Polypharmacy in Heart Failure Patients. Curr Heart Fail Rep. 11(2):212-219.
McMurray, J. J. V, S. Adamopoulos, S. D. Anker, A. Auricchio, M. Böhm, K. Dickstein, V. Falk, G. Filippatos, C. Fonseca, M. A. Gomez-Sanchez, T. Jaarsma, L. Køber, G. Y. Lip, A. P. Maggioni, A. Parkhomenko, B. M. Pieske, B. A. Popescu, P. K. Rønnevik, F. H. Rutten, J. Schwitter, P. Seferovic, J. Stepinska, P. T. Trindade, A. A. Voors, F. Zannad & A. Zeiher. 2012. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Heart. Eur Heart J. (32)641-661. McMurray, J. J. V. & S. Stewart. 2003. The burden of heart failure. Eur Heart J. 5(Suppl):13-113. Musher, D. M., A. M. Rueda, A. S. Kaka & S. M. Mapara. 2007. The association between pneumococcal pneumonia and acute cardiac events. Clin Infect Dis. 45(2):158-65. Naing, L, T. Winn, & B. N. Rusli. 2006. Practical Issues in Calculating the Sample Size for Prevalence Studies. Arch Orofac Sci. 1:9-14. National Kidney Foundation, K/DOQI. 2002. Clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis. 39(2 Suppl 1):S1-266. Oemar, H. 2002. Anatomi Jantung dan Pembuluh Darah dalam Buku Ajar Kardiologi. Jakarta: Balai Penerbit Fakultas Kedokteran Indonesia; hal. 713. Oktavia, Sri. S. Dharma & A. M. Hanif. 2013. Evaluasi Penggunaan Kombinasi Angiotensin Converting Enzyme Inhibitor dengan Furosemide Terhadap Fungsi Ginjal Pasien Gagal Jantung Kongestif di RSUP Dr. M. Djamil Padang. Prosiding Seminar Nasional Perkembangan Terkini Sains Farmasi dan Klinik III. 279-286. Osadchii, Oleg E. 2010. Mechanisms of hypokalemia-induced ventricular arrhythmogenicity. Fundam Clin Pharmacol. 24:547–559. Owusu, I. 2006. Treatment of Heart Failure in a Teaching Hospital in Ghana, West Africa. Medicine. 4:2. Park, L. W., D. Yoon, G. T. Shin, H. Kim & R. W. Park. 2014. Onset time of hyperkalemia after angiotensin receptor blocker initiation: when should we start serum potassium monitoring?. J Clin Pharm Ther. 39: 61-68. Paul, B., N. C. Wilfred, R. Woodman & C. DePasquale. 2008. Hypertension Prevalence and Correlates of Anemia in Essential Hypertension. Clin Exp Pharmacol Physiol. 35:1461–1464. PERKI. 2015. Pedoman Tatalaksana Gagal Jantung. Perhimpunan Dokter Spesialis Kardiovaskular Indonesia.
Peterson, P. N., S. M. Shetterly, C. L. Clarke, D. B. Bekelman, P. S. Chan, L. A. Allen, D. D. Matlock, D. J. Magid & F. A. Masoudi. 2011. Health Literacy and Outcome Among Patients With Heart Failure. JAMA. 305(16): 16951701. Pitt, B. & P. Rossignol. 2016. The association between serum potassium and mortality in patients with hypertension: ‘a wake-up call’. Eur Heart J. doi:10.1093/eurheartj/ehw209 Pocock, S.J., D. Wang, M. A. Pfeffer, S. Yusuf, J. J. V. McMurray, K. B. Swedberg, J. O¨stergren, E. L. Michelson, K. S. Pieper & C. B. Granger. 2006. Predictors of mortality and morbidity in patients with chronic heart failure. Eur Heart J. 27:65–75. Ponikowski, P., A. A. Voors, S. D. Anker, H. Bueno, J. G. Cleland, A. J. Coats, V. Falk, J. R. González-Juanatey, V. P. Harjola, E. A. Jankowska, M. Jessup, C. Linde, P. Nihoyannopoulos, J. T. Parissis, B. Pieske, J. P. Riley, G. M. Rosano, L. M. Ruilope, F. Ruschitzka, F. H. Rutten & P. van der Meer. 2016. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J Fail. 18(8):891-975. Ponikowski, P., S. D. Anker, K. F. AlHabib, M. R. Cowie, T. L. Force, S. Hu, T. Jaarsma, H. Krum, V. Rastogi, L. E. Rohde, U. C. Samal, H. Shimokawa, B. B. Siswanto, K. Sliwa, G. Filippatos. 2014. Heart Failure: Preventing Disease and Death Worldwide. ESC Heart Failure. 1: 4–25. Pusat Data dan Informasi Kemenkes RI. 2012. Gambaran Penyakit Tidak Menular Di Rumah Sakit Di Indonesia Tahun 2009 dan 2010. Kementerian Kesehatan Republik Indonesia. Raebel, M. A. 2012. Hyperkalemia Associated with Use of AngiotensinConverting Enzyme Inhibitors and Angiotensin Receptor Blockers. Cardiovasc Ther. 30:156–166. Ramadan, F. H., N. Masoodi & A. A. El-Solh. 2005. Clinical factors associated with hyperkalemia in patients with congestive heart failure. J Clin Pharm Ther. 30: 233-239. Rao, K., M. L. Fisher, S. Robinson, S. Shorofsky & S. S. Gottlieb. 2007. Effect of Chronic Changes in Heart Rate on Congestive Heart Failure. J Card Fail. 13(4):269-274. Robertson, J. P. McElduff, S. Pearson, D. A. Henry, K. J. Inder & J. R. Attia. 2012. The health service burden of heart failure: an analysis using linked population health data-sets. BMC Health Serv Res 12:103-114. Rogers, A., J. M. Addington-Hall , A. S.M. McCoy, P. M. Edmonds, A. J. Abery, A. J.S. Coats, J. S. R. Gibbs. 2002. A qualitative study of chronic heart failure patients’ understanding of their symptoms and drug therapy. Eur J Heart Fail. 4(3):283-287.
Romanovsky, A., S, Bagshaw & M. H. Rosner. Hyponatremia and Congestive Heart Failure: A Marker of Increased Mortality and a Target for Therapy. Int J Nephrol. doi: 10.4061/2011/732746 Rosamond, W., K. Flegal & G. Friday. 2007. Heart disease and stroke statistics2007 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Cirlulation; 115: 69-171. Rose, B. D. & T. W. Post. 2001. Renal circulation and glomerular filtration rate. McGraw- Hill.Ruwald, M.H.,M. L. Hansen, M. Lamberts, C. M. Hansen, M. Vinther, L. Køber, C. Torp-Pedersen, J. Hansen, & G. H. Gislason. 2013. Prognosis Among Healthy Individuals Discharged With a Primary Diagnosis of Syncope. J Am Col Cardiol. 61(3): 325–332. Ryeden, L. P. J. Grant, S. D. Anker, C. Berne, F. Cosentino, N. Danchin, C. Deaton, J. Escaned, H. P. Hammes, H. Huikuri, M. Marre, N. Marx, L. Mellbin, J. Ostergren, C. Patrono, P. Seferovic, M. S. Uva, M. R. Taskinen, M. Tendera, J. Tuomilehto, P. Valensi & J. L. Zamorano. 2013. ESC Guidelines on diabetes, pre-diabetes, and cardiovascular disease develop in collaboration with the EASD. Eur Heart Jl. 34(39):3035-3087. Saczynski, J. S., A. S. Go, D. J. Magid, D. H. Smith, D. D. McManus, L. Allen, J. Ogarek, R. J. Goldberg & J. H. Gurwitz. 2013. Patterns of Comorbidity in Older Patients with Heart Failure. J Am Geriatr Soc. 61(1): 26–33. Saito, M., M. Takada, K. Hirooka, F. Isobe & Y. Yasumura. 2005. Serum concentration of potassium in chronic heart failure patients administered spironolactone plus furosemide and either elapril maleate, losartan potassium or candesartan cilexetil. J Clin Pharm Ther. 30: 603-610. Sarafidis, P. A., R. Blacklock, E. Wood, A. Rumjon, S. Simmonds, J. FletcherRogers, R. Ariyanayagam, A. Al-Yassin, C. Sharpe & K. Vinen. 2012. Prevalence and factors associated with hyperkalemia in predialysis patients followed in a low-clearance clinic. Clin J Am Soc Nephrol.7:12341241. Sato, N., K. Kajimoto, K. Asai, M. Mizuno, Y. Minami Y, M. Nagashima, K. Murai, R. Muanakata, D. Yumino, T. Meguro, M. Kawana, J. Nejima, T. Satoh, K. Mizuno, K. Tanaka, H. Kasanuki & T. Takano. 2010. Acute decompensated heart failure syndromes (ATTEND) registry.Aprospective observational multicenter cohort study: rationale, design, and preliminary data. Am Heart J. 159:949–955. Scanlon, T. & V. C. Sanders. 2007. Essential of Anatomy and Physiology (7th Ed). Philadelphia: F. A. Davis Company. Scottish Intercollegiate Guidelines Network. 2008. Diagnosis and management of chronic kidney disease. Edinburgh: Elliot House.
Segal, Omer, G. Segal, A. Leibowitz, I. Goldenberg, E. Grossman, & R. Klempfner. 2017. Elevation in systolic blood pressure during heart failure hospitalization is associated with increased short and long-term mortality. Medicine. 96(5):1-7. Setiawati, A dan Nafrialdi. 2007. Gagal Jantung dalam Sulistia G. ganiswara, Rianto Setiabudi, Frans D. Suyatna, Purwantyastuti dan Nafrialdi. Farmakologi Dan Terapi. Edisi 4. Jakarta:Departemen Farmakologi dan Terapeutik FKUI. Shamsham, F & J. Mitchell. 2000. Essentials of the Diagnosis of Heart Failure. Am Fam Physician. 61(5):1319-1328. Sica, D. A. 2005. Hyponatremia and heart failure—pathophysiology and implications. Congest Heart Fail. 11:274–277 Sitompul, B. dan J. I. Sugeng. 2002. Gagal Jantung dalam Buku Ajar Kardiologi. Jakarta: Balai Penerbit Fakultas Kedokteran Indonesia. Snell, R. S. 1997. Clinical Anatomy for Medical Student (3th Ed). Diterjemahkan oleh Adji Dharma; Anotomi Klinik untuk mhasiswa Kedokteran (Edisi 3). Jakarta: Penerbit Buku Kedokteran EGC. Suryadipra, R. M. 2006. Gagal Jantung dan Penatalaksanaannya dalam Buku Ajar Penyakit Dalam, Edisi Keempat Jilid I. Jakarta: Pusat Penerbitan Departemen Ilmu Penyakit Dalam FKUI. Suwitra, K. 2014. Penyakit ginjal kronik. Dalam Sudoyo AW, Setiyohadi B, Alwi I, SimadibrataM, Setiati S, editor. Buku ajar ilmu penyakit dalam. Edisi 6. Jakarta: Pusat Penerbitan Ilmu Penyakit Dalam. Swedberg, K. & Michel Komajda. On the Importance of Heart Rate in Chronic Heart Failure. Eur Heart J. 2012;33(9):1044-1045. Tegegne, G. T., B. K. Gelaw, A. D. Defersha, B. Yiman & E. A. Yesuf. 2014. Drug Therapy Problem (DTP) Among Patients with Cardiovascular Disease in Felege Hiwot Referral Hospital, North East, Bahir Dar Ethiopia. Indo American Journal of Pharmaceutical Research. 2828-2838. The RALES Investigators. Effectiveness of spironolactone added to an angiotensin-converting enzyme inhibitor and a loop diuretic for severe chronic congestive heart failure (the randomized aldactone evaluation study [RALES]). Am J Cardiol 1996;78:902–907. Trujillo, J. M., M. J. Gonyeau, M. V. DiVall & S. L. Alexander. 2004. Spironolacton use in patient with heart failure. J Clin Pharm Ther. (29): 165-170. Urso, C., S. Brucculeri & G. Caimi. 2015. Acid–base and electrolyte abnormalities in heart failure: pathophysiology and implications. Heart Fail Rev. DOI 10.1007/s10741-015-9482-y
Velentgas, P., N. A. Dreyer, P. Nourjah, S. R. Smith, M. M. Torchia. 2013. Developing a Protocol for Observational Comparative Effectiveness Research: A User’s Guide. AHRQ Publication No. 12(13)-EHC099. Rockville, MD: Agency for Healthcare Research and Quality Wessly, P., S. Soherwardi & C. Gandotra. 2016. Hyponatremia in Congestive Failure: Evidence Based Management. Austin Intern Med. 1(1): 1004. Wong, C. Y., S. I. Chaudhry, M. M. Desai & H. M. Krumholz. 2013. Trends in Comorbidity, Disability, and Polypharmacy in Heart Failure. Am J Med. 124:136-143. World Heart Federation. 2014. Cardiovascular Disease: Risk Factor. Geneva. Wright, S. P. D. Verouhis , G. Gamble , K. Swedberg , N. Sharpe & R.N. Doughty. 2003. Factors influencing the length of hospital stay of patients with heart failure. Eur J Heart Fail. (5):201–209. Yancy, C. W., M. Jessup, V. Chair, B. Bozkurt, J. Butler, D. E. Casey, M. H. Drazner, G. C. Fonarow, S. A. Geraci, T. Horwich, J. L. Januzzi, M. R. Johnson, E. K. Kasper, W. C. Levy, F. A. Masoudi, P. E. McBride, J. J. V. McMurray, J. E. Mitchell, P. N. Peterson, B. Riegel, F. Sam, L. W. Stevenson, W. H. Wilson Tang, E. J. Tsai & B. L. Wilkoff. 2013. ACCF/AHA Guideline for the Management of Heart Failure. J Am Coll Cardiol. 62(16): 147–239. Yildiran, T., Mevlut Koc, A. Bozkurt, D. Y. Sahin, I. Unal & E. Acarturk. 2010. Low Pulse Pressure as a Predictor of Death in Patients with Mild to Advanced Heart Failure. Tex Heart Inst J. 37(3):284-90. Yogiantoro, M. 2014. Pendekatan klinis hipertensi. Dalam Sudoyo AW, Setiyohadi B, Alwi I, Simadibrata M, Setiati S, editor. Buku ajar ilmu penyakit dalam. Edisi 6. Jakarta: Pusat Penerbitan Ilmu Penyakit Dalam. Zannad, F., A. A. Garcia, S. D. Anker, P. W. Armstrong,G. Calvo, J. G.F. Cleland, K. Dickstein, M. J. Domanski, I. Ekman, G. S. Filippatos, M. Gheorghiade, A. F. Hernandez, T. Jaarsma, J. Koglin, M. Konstam, S. Kupfer, A. P. Maggioni, A. Mebazaa, M. Metra, C. Nowack, B. Pieske, I. L. Piña, S. J. Pocock, P. Ponikowski, G. Rosano, L. M. Ruilope, F. Ruschitzka, T. Severin, S. Solomon, K. Stein, N. L. Stockbridge, W. G. Stough, K. Swedberg, L. Tavazzi, A. A. Voors, S. M. Wasserman, H. Woehrle, A. Zalewski & J. J. McMurray. 2013. Clinical outcome eddpoint in heart failure trials: a European Society of Cardiology Heart Failure Association consensus document. Eur J Heart Fail. 15: 1082-1094. Zaprutko, J., M. Michalak, A. Nowicka, R. Dankowski, J. Drożdż, P. Ponikowski, G. Opolski, J. Nessler, E. Nowalany-Kozielska & A. Szyszka. 2016. Hospitalization length and prognosis in heart failure patients. Kardiol Pol. doi: 10.5603/KP.a2016.0183.
